Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of the pathway of apoptosis involving PAR-4, DAXX and ZIPK proteins in CLL patients and its relationship with the principal prognostic factors.
Bojarska-Junak A, Sieklucka M, Hus I, Wąsik-Szczepanek E, Kusz ML, Surdacka A, Chocholska S, Dmoszyńska A, Roliński J. Bojarska-Junak A, et al. Among authors: dmoszynska a. Folia Histochem Cytobiol. 2011;49(1):98-103. doi: 10.5603/fhc.2011.0014. Folia Histochem Cytobiol. 2011. PMID: 21526495 Free article.
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
Giannopoulos K, Dmoszynska A, Kowal M, Wasik-Szczepanek E, Bojarska-Junak A, Rolinski J, Döhner H, Stilgenbauer S, Bullinger L. Giannopoulos K, et al. Among authors: dmoszynska a. Leukemia. 2009 Oct;23(10):1771-8. doi: 10.1038/leu.2009.98. Epub 2009 May 14. Leukemia. 2009. PMID: 19440214
TLR2 may influence the behavior of the malignant clone in B-CLL.
Antosz H, Sajewicz J, Marzec-Kotarska B, Dmoszyńska A, Baszak J, Jargiełło-Baszak M. Antosz H, et al. Among authors: dmoszynska a. Blood Cells Mol Dis. 2012 Jun 15;49(1):32-40. doi: 10.1016/j.bcmd.2012.03.006. Epub 2012 Apr 21. Blood Cells Mol Dis. 2012. PMID: 22521894 Clinical Trial.
TP53 polymorphism in plasma cell myeloma.
Zmorzynski SA, Korszen-Pilecka I, Wojcierowska-Litwin M, Kwiatkowska-Drabik B, Luterek M, Chocholska S, Koczkodaj D, Popek S, Michalak-Wojnowska M, Swiderska-Kolacz G, Januszewska J, Surowiec I, Tomczak W, Hus M, Dmoszynska A, Pasiarski M, Poniewierska-Jasak K, Cieplinska K, Jankowska-Lecka O, Filip AA. Zmorzynski SA, et al. Among authors: dmoszynska a. Folia Histochem Cytobiol. 2017;55(4):203-211. doi: 10.5603/FHC.a2017.0022. Epub 2018 Jan 15. Folia Histochem Cytobiol. 2017. PMID: 29333597
Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
Antosz H, Sajewicz J, Marzec-Kotarska B, Dmoszyńska A, Baszak J, Jargiełło-Baszak M. Antosz H, et al. Among authors: dmoszynska a. Blood Cells Mol Dis. 2013 Jun;51(1):48-55. doi: 10.1016/j.bcmd.2013.01.011. Epub 2013 Feb 15. Blood Cells Mol Dis. 2013. PMID: 23419703
ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value.
Hus I, Bojarska-Junak A, Dmoszyńska A, Wasik-Szczepanek E, Sieklucka M, Trześniewska W, Glazer M, Roliński J. Hus I, et al. Among authors: dmoszynska a. Folia Histochem Cytobiol. 2008;46(2):147-52. doi: 10.2478/v10042-008-0022-7. Folia Histochem Cytobiol. 2008. PMID: 18519230 Free article.
254 results